APOE genotype and MRI markers of cerebrovascular disease

Neurology

Volumn 81, Issue 3, 2013, Pages 292-300

  Schilling, Sabrina ^a,b,c   DeStefano, Anita L ^d   Sachdev, Perminder S ^f,g   Choi, Seung Hoan ^d   Mather, Karen A ^g   DeCarli, Charles D ^h   Wen, Wei ^f   Høgh, Peter ⁱ   Raz, Naftali ^j   Au, Rhoda ^e   Beiser, Alexa ^d,e   Wolf, Philip A ^e   Romero, José Rafael ^e   Zhu, Yi Cheng ^b   Lunetta, Kathryn L ^d   Farrer, Lindsay ^e   Dufouil, Carole ^b,c   Kuller, Lewis H ^k   Mazoyer, Bernard ^c,l   Seshadri, Sudha ^e   Tzourio, Christophe ^b,c   Debette, Stéphanie ^a,b,e   more..

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PRINCE OF WALES HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Mental Health Services CPH   (Denmark)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^l NRS CEA UMR6232 Centre for Imaging Neuroscience and Application to Pathologies Caen   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEIN E44; UNCLASSIFIED DRUG;

BRAIN HEMORRHAGE; BRAIN INFARCTION; DISEASE SEVERITY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WHITE MATTER LESION;

ALLELES; APOLIPOPROTEINS E; BRAIN; CEREBROVASCULAR DISORDERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; RISK;

EID: 84881297582     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829bfda4     Document Type: Review

References (60)

1. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimers disease and other neurological disorders. Lancet Neurol 2011;10:241-252
2. Hogh P, Garde E, Mortensen EL, Jorgensen OS, Krabbe K, Waldemar G The apolipoprotein E epsilon4- allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. Acta Neurol Scand 2007 115 248-253
3. Godin O, Tzourio C,Maillard P, Alperovitch A, Mazoyer B, Dufouil C. Apolipoprotein E genotype is related to progression of white matter lesion load. stroke 2009;40:3186-3190
4. Schmidt H, Schmidt R, Fazekas F, et al. Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 1996;50:293-299
5. Lunetta KL, Erlich PM, Cuenco KT, et al. Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study. Alzheimer Dis Assoc Disord 2007;21:85-91
6. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis: APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356
7. Sudlow C, Martinez Gonzalez NA, Kim J, Clark C. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke 2006;37: 364-370
8. Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010;68:934-943
9. Biffi A, Anderson CD, Jagiella JM, et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 2011;10:702-709
10. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341: c3666.
11. Schuur M, van Swieten JC, Schol-Gelok S, et al. Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population. J Neurol Neurosurg Psychiatry 2011;82:41-44
12. Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan Study. Stroke 2010;41:S103-S106
13. Vuorinen M, Solomon A, Rovio S, et al. changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study. Dement Geriatr Cogn Disord 2011;31:119-125
14. Vermeer SE, Longstreth WT, Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-619
15. Debette S, Bis JC, Fornage M, et al. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 2010;41:210-217
16. Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011;69:928-939
17. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003;22: 316-325
18. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010;41:600-606
19. Jeerakathil T,Wolf PA, Beiser A, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004;35:1831-1835
20. Sachdev PS, Brodaty H, Reppermund S, et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 2010;22: 1248-1264
21. Lemmens R, Gorner A, Schrooten M, Thijs V. Association of apolipoprotein E e2 with white matter disease but not with microbleeds. Stroke 2007;38:1185-1188
22. Goos JD, Kester MI, Barkhof F, et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009;40:3455-3460
23. Schmidt R, Schmidt H, Fazekas F, et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke 1997;28:951-956
24. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke 1999;30:1548-1553
25. Nebes RD, Vora IJ, Meltzer CC, et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry 2001;158:878-884
26. de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004;35:1057-1060
27. Crisby M, Bronge L, Wahlund LO. Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases. Curr Alzheimer Res 2010;7: 534-539
28. Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke 2000;31: 1263-1268
29. Sawada H, Udaka F, Izumi Y, et al. Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimers disease. J Neurol Neurosurg Psychiatry 2000;68:653-656
30. Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimers disease? J Neurol Neurosurg Psychiatry 2000;69:668-671
31. Szolnoki Z, Somogyvari F, Kondacs A, et al. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurol Scand 2004;109:222-227
32. Bracco L, Piccini C, Moretti M, et al. Alzheimers disease: role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord 2005;20:358-366
33. Wen HM, Baum L, Cheung WS, et al. Apolipoprotein E epsilon4 allele is associated with the volume of white matter changes in patients with lacunar infarcts. Eur J Neurol 2006;13:1216-1220
34. Seifert T, Lechner A, Flooh E, Schmidt H, Schmidt R, fazekas F. Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis 2006;21:266-270
35. Raz N, Yang Y, Dahle CL, Land S. Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta 2012;1822:361-369
36. Hafsteinsdottir SH, Eiriksdottir G, Sigurdsson S, et al. Brain tissue volumes by APOE genotype and leisure activitythe AGES-Reykjavik Study. Neurobiol Aging 2012;33:829. e1-8
37. Kuller LH, Shemanski L, Manolio T, et al. relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke 1998;29:388-398
38. Steffens DC, Trost WT, Payne ME, Hybels CF, MacFall JR. Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. Biol Psychiatry 2003;54:674-681
39. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging 2009;30:946-956
40. He J, Iosif AM, Lee DY, et al. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol 2010;67:1231-1237
41. Biffi A, Anderson CD, Desikan RS, et al. Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol 2010;67:677-685
42. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry 2008;79:1002-1006
43. Kim M, Bae HJ, Lee J, et al. APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI. Neurology 2005;65:1474-1475
44. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006;66: 1356-1360
45. Paternoster L, Chen W, Sudlow CL. Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 2009;40:2020-2026
46. Cherbuin N, Leach LS, Christensen H, Anstey KJ. Neuroimaging and APOE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord 2007;24:348-362
47. Rost NS, Greenberg SM, Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke 2008;39: 2166-2173
48. Greenberg SM. Cerebral amyloid angiopathy and vessel dysfunction. Cerebrovasc Dis 2002;13(suppl 2):42-47
49. Tanskanen M, Makela M, Myllykangas L, et al. Prevalence and severity of cerebral amyloid angiopathy: a populationbased study on very elderly Finns (Vantaa 851). Neuropathol appl Neurobiol 2012;38:329-336
50. McCarron MO, Nicoll JA, Stewart J, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999;58:711-718
51. Smith EE, Nandigam KR, Chen YW, et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke 2010;41:1933-1938
52. Zhu YC, Chabriat H, Godin O, et al. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol 2012;259:530-536
53. Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2011;37:75-93
54. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34: 806-812
55. Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 2012; 78:720-727
56. Maxwell SS, Jackson CA, Paternoster L, et al. Genetic associations with brain microbleeds: systematic review and meta-analyses. Neurology 2011;77:158-167
57. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001;56:537-539
58. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-174
59. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol 2009;8:643-653
60. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.